The effect of 12 weeks of estriol cream on stress urinary incontinence post‐menopause: A prospective multinational observational study
Neurourology and Urodynamics · 2023
DOI: 10.1002/nau.25165 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Neurourology and Urodynamics, 2023. Verfasst von Nevine I D Te West und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urogynaecology, St George Hospital, School of Women's and Children's Health, University of New South Wales, Sydney, Australia. Hauptthemen laut MEDLINE: Urinary Incontinence, Stress. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Themen: Inkontinenz
Abstract (Originalsprache)
Objective
To quantitate the changes in stress urinary incontinence (SUI) outcome measures after 12 weeks of vaginal estriol cream in women with stress incontinence.
Methods
A prospective multicentre observational study conducted in tertiary urogynaecology centers. Postmenopausal women with pure SUI or stress predominant mixed urinary incontinence (MUI), not receiving any other treatment for their incontinence were given written instructions regarding digital application of a standard dose of vaginal estriol cream. Outcomes were measured at baseline and 12 weeks. The primary objective outcome was vaginal pH. The primary subjective outcome was the stress domain of the Urogenital Distress Inventory‐6 (UDI‐6). The secondary objective outcome used was the erect cough stress test. Two quality of life questionnaires and two patient reported outcomes were also included.
Results
The 46 postmenopausal recruits had a median age of 62.1 interquartile range (IQR 56.2–65.4). At follow up, the primary subjective outcome SUI domain [UDI‐6] significantly improved from 83.3 (IQR 50–100) to 33.3 (33.3–66.7, p ≤ 0.001) as did vaginal pH [from 5.1 (4.9–5.9) to 4.9 (4.6–5.0] p ≤ 0.001; 18/43 patients (42%) were dry on cough stress test.
Conclusions
Twelve weeks of vaginal estriol cream significantly reduced symptoms of stress urinary incontinence in this sample of postmenopausal women.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Urogynaecology, St George Hospital, School of Women's and Children's Health, University of New South Wales, Sydney, Australia.
- The George Institute for Global Health, University of New South Wales, Sydney, Australia.
- Department of Obstetrics and Gynaecology, Groote Schuur Hospital, Cape Town, South Africa.
- Department of Obstetrics and Gynaecology, Academic Medical Center, Amsterdam, The Netherlands.
ORCID-Profile: Nevine I D Te West, Kate H Moore
Zitieren
APA
Te West, N. I. D., Harris, K., Jeffrey, S., de Nie, I., Parkin, K., Roovers, J. P., & Moore, K. H. (2023). The effect of 12 weeks of estriol cream on stress urinary incontinence post‐menopause: A prospective multinational observational study. Neurourology and Urodynamics. https://doi.org/10.1002/nau.25165
Vancouver
Te West NID, Harris K, Jeffrey S, de Nie I, Parkin K, Roovers JP, et al. The effect of 12 weeks of estriol cream on stress urinary incontinence post‐menopause: A prospective multinational observational study. Neurourology and Urodynamics. 2023. doi:10.1002/nau.25165
BibTeX
@article{TeWest2023,
author = {Te West, Nevine I D and Harris, Katie and Jeffrey, Steven and de Nie, Iris and Parkin, Katrina and Roovers, Jan-Paul and Moore, Kate H},
title = {The effect of 12 weeks of estriol cream on stress urinary incontinence post‐menopause: A prospective multinational observational study},
journal = {Neurourology and Urodynamics},
year = {2023},
doi = {10.1002/nau.25165}
}
EUVIMED